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Abstract 
Blalock-Taussig Shunt provides palliation for patients with cyanotic congenital heart diseases, 
where an intracardiac shunting from right-to-left with inadequate pulmonary blood flow. From June 
(1993) to June (2015), a retrospective study was conducted on 29  patients with complex congenital 
cyanotic heart diseases.They underwent Blalock-Taussig Shunt at Ibn Albitar Hospital for Cardiac 
Surgery. Both classical (n=4) and modified Blalock-Taussig Shunts (n=25) were done. The underlying 
cyanotic congenital heart diseases included tetraology of fallot (n=14), transposition of great arteries 
(n=6), tricusp atrasia (n=3), double outlet ventricle (n=5) and pulmonary stenosis with atrial septal 
defect (n=1). The age of patients at the operation ranged between 2 weeks to 13 years with a mean age 
of 49 ± 59, and the patients' weight ranged between 3-30 Kg with a mean weight of 11.3 ± 7.5.All 
shunts were performed through left or right lateral thoracotomy via fourth intercostal space. In 
modified Blalock-Taussig Shunts, different sizes of PTFE vascular grafts ranged between 3 to 8 mm 
were used . Echocardiographic studies were performed for all patients, but cardiac catheterizations 
were less frequently used. Shunt patency and length of satisfactory palliation for all patients were 
determined by different criteria. The overall mortalities were 12 patients. The majority of their deaths 
was related to shunt failure. Early deaths were recorded for 7 patients, 5 of them were related to shunt 
failure, and other 2 deaths are irrelative to shunt failure. Late deaths were 5 shunts. The overall shunt 
failures were 12 shunts. Most of shunt failures occurred in patients with main pulmonary artery size 
6mm using graft size 6mm in modified Blalock-Taussig Shunt. In conclusions, Blalock-Taussig Shunt 
is good palliation for cyanotic congenital heart diseases. 
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ةصلاخلا 
 لخاد ةميوحت دوجو ببسب ةياقرزلاا ةيدلاولا بمقلا تاىوشت نم نوناعي نيذلا ىضرممل يفيفخت جلاعك مدختست كول لاب ةميصوت
بمقلا ةمضع .يوئرلا نايرشلا يف مدلا صقن عم بمقمل رسيلاا بناجلا ىلا نميلاا بناجلا نم مدلا راسمل 
 ل ةيحارجلا جئاتنلا ىمع ءوضلا طمست دادغب يف بمقلا ةحارجل راطيبلا نبا ىفشتسم يف تيرجا ةيداعتسا ةسارد92  ضيرم
نم ميتلاحا تمت  ةياقرزلااو  ةدقعملا ةيدلاولا بمقلا تاىوشتب نيباصم  مادختسا قيرط نع يحارجلا جلاعلا يقمتل ةينطابلا ماسقا
 نم ةرتفملو كوللاب ةميصوت10 \ 10 \ 0221  ةياغلو10 \ 09 \ 9102  ( ل ةيكيسلاكلا كوللاب ةميصوت مادختسا مت  ثيح4  )
 ( مىددع غلابلاو نيرخلاا ىضرملا امنيب طقف ىضرم92 ناك ثيح ةلدعملا كوللاب ةميصوت مادختسا  مت )   نم نوناعي ىضرملا
: يتلاا  وحنلا ىمع ةياقرزلااو ةدقعملا ةيدلاولا بمقلا تاىوشت- (04  ( ,   تولاف ةيعابر نم يناعي ضيرم )6  نايرشلا ساكعنا )
 ( ,  ةيسيئرلا1  ( , يثلاثلا مامصلا قلاغنا )2  (,   جرخملا يئانث نيطب )0 .  نينيذلاا نيب ةحتف عم يوئرلا مامصلا قيضت ) 
 ( رشع ةثلاث ىلا نيعوبسا نيب حوارتت تناك ةيممعلا ءارجا ءانثا ىضرملا رامعا01  نيب  حوارتت تناك مينازوا امنيب تاونس )
1  ىلا11  ماجحا مادختسا مت ةلدعملا كوللاب ةميصوت ةيممع يف و ردصلا حتف ةيممع قيرط نع اىؤارجا مت تايممعلا عيمجو مارغ وميك
عتملا ءاعولا نم ةددعتم (  نيب حوارتت يعانصلا نيميثا ورومف يثلاثلا دد1  (  ىلا )8  .رتميمم ) 
 ةرتف و  ةميوحتلا ةيكلاس نا ثيح لقا بسنب ومادختسا  مت بمقلا ةرطسق صحف امنيب ىضرملا لكل هؤارجا مت وكيلاا صحف
ع ناك ثيح ةفمتخم تافصاوم للاخ نم اىديدحت مت ىضرملا عيمجل يفيفختلا جلاعلا ةيلاعف  ( وى نيفوتملا ىضرملا دد09  ضيرم )
 (  وى مييدل يسيئرلا  يوئرلا نايرشلا مجح ناك ىضرمل  ةميصوتلا لشف بسسب ميمظعم6  مجحب يعانص ءاعو مادختسا عم رتميمم )
 (6 ب ةميصوت مادختسا  نا يى ةيئاينلا ةمصحملا ناف  كلذ نم مغرلابو ةلدعملا كوللاب ةميصوت ةيممع ءانثا رتميمم ) ربتعي  كوللا
. ةياقرزلااو ةدقعملا ةيدلاولا بمقلا تاىوشت جلاع يف ديج رايخ 
 
: ةيحاتفملا تاممكلا-  يفيفختلا جلاعلا , يعانصلا نيميثا ورومف يثلاثلا ددعتملا ءاعولا  , كول لاب ةميصوت. 
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Introduction  
I.1 Historical Aspects:-After 1944, when the first Blalock-Taussig operation was 
developed, many blue babies were saved from invalidism or death [ Aubreyc , 
2014] . The first operation was performed on November 28, 1944, on a 15-months-
old girl with the diagnosis of tetralogy of Fallot and severe pulmonary stenosis, 
that was published in 1945[Carl, 2013 ].  
I-2 Pathophysiology of CCHD:- Right-to-left shunting of systemic venous blood 
directly into the systemic circulation results in arterial hypoxemia and cyanosis[  
William G 1998].The degree of cyanosis depends on the degree of anoxia and the 
blood hemoglobin concentration (Hb)[Jesse E.E 1990].Cyanosis from intra cardiac 
shunt is unresponsive (or only minimally responsive) to an increase in the fraction 
of inspired oxygen. The intensity of the cyanosis is related to the volume of 
pulmonary blood flow. This was the rational for palliative systemic to pulmonary 
artery shunts to increase pulmonary blood flow[Sabiston 2015].Clinical features of 
chronic cyanosis are much less commonly seen now than they were before because 
of early diagnosis and effective surgical treatment that became available for most 
forms of cyanotic congenital heart disease[William G.,1998]. A decrease in 
exercise tolerance, with dyspnea on exertion, is a characteristic feature of cyanotic 
heart disease[Keui-T 1996]. Periodic episodes of unconsciousness, termed hyper 
cyanotic spells, are signs of cerebral anoxia[Vobecky,1993]. Another cause of 
neurological injury in cyanotic children is brain abscess[Alcibar-J,1994]. Other 
clinical feature includes development of aortopulmonary collateral vessels failure 
to grow, metabolic acidosis, and respiratory distress[Sabiston, 2016]. 
I-3   Indications of BTS:- Any intra cardiac defect produces right-to-left shunting of 
unoxygenated venous blood with inadequate pulmonary circulation, to improve the 
pulmonary blood flow and decrease the cyanosis, if early total repair is not 
feasible[Mills WI 1985]. These intra cardiac defects include for example:- 
Tetralogy of Fallot (TOF) , Tricuspid Atresia (T.Atr.)  and Pulmonary Atresia 
(P.Atr.) [ Steven ,1996]. 
I-4 The Principles of Blalock – Taussig Shunt (BTS):-Blalock described the 
procedure as an anastomosis of the end of the divided subclavian artery to the side 
of the pulmonary artery. The classical shunt is generally done on the side of the 
chest containing the innominate artery; because the aortic arch and the innominate 
artery are always opposite to each other[Stewart , 1988]. Experimental studies have 
shown that approximately  an amount of three quarters of the blood passing 
through a subclavian pulmonary shunt is directed to the lung on the side of the 
anastomosis[Pappas , 1982].
 
 
I-5   Advantages of CBTS:- It has a lower  incidence of post-operative congestive 
heart failure and other post-operative complications evolved by central systemic – 
pulmonary shunt . Shunt flow is limited by the diameter of the subclavian artery 
[Kirklin-JW 2012]. The shunt may grow with the child, often allowing many years 
of palliation , Distortion of the pulmonary artery is uncommon[Rebecca ,1987]. 
Ligation of the shunt is often easier than taking-down of central aorto pulmonary 
shunts at the time of corrective procedures [Deleval MR 1981]. 
I-6   Disadvantages of CBTS:- It requires meticulous and time consuming dissection 
which may be difficult to justify in a severely ill infant[Odim-J,1995] , It can 
distort the peripheral pulmonary artery . It can cause shunt thrombosis or 
inadequate flow ,injury to the phrenic nerve, ventilator dependence, and need for 
diaphragmatic plication[Daniel ,1990],Horner's syndrome, hemorrhage from hilar 
collaterals, and lymphatic leak with chylothorax  . When the subclavian artery is 
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divided, gangrene of the arm may occur in less than 1% of cases [Tometcki-
AI,1995]. Pulmonary hypertension may develop and some infants do not have 
suitable anatomy because of the an unusual narrow or  the short subclavian 
artery[Sethia ,1986]. 
I-7 Modified Blalock-Taussig Shunt (MBTS):- With the advent of reliable 
prosthetic graft material, technically easier forms of systemic-to-pulmonary artery 
shunting as means of palliation have become popular. Moreover  because patients 
return within 2 years for total correction, the temporary nature of palliation justifies 
the use of an artificial conduit that may not have optimal longevity but that does 
preserve the subclavian arterial supply to the arm [Karpawich ,1985]. The Great 
Omond Street group popularized the  MBTS consisting of side to side anastomosis 
between subclavian and pulmonary arteries using a polytetrafluoroethylene (PTEE) 
interposition graft, has become increasingly popular as an alternative to the 
classical shunt [Turner S.1995]. After vascular control, a small longitudinal 
incision is made in inferior aspect of the subclavian artery and an end-to-side 
anastomosis completes between the artery and the PTFE graft with continuous 
polypropylene suture [Edmunds ,1990]. 
 I-8 Advantages of MBTS:- It can be performed through a right or left thoracotomy 
or a median stemotomy , more easily in neonates than classical shunt . Greater 
growth and less distortion of the pulmonary artery ,graft thrombosis is uncommon, 
and has been successfully treated . High early patency rate with less frequent early 
and late graft failure ,congestive heart failure is as uncommon  and preservation of 
the subclavian artery[Mullen ,1996]. 
 
I-9 Disadvantages of MBTS:-Because the graft is fixed in size, distortion of the 
pulmonary artery by the shunt can be anticipated as the patient grows, These shunts 
can be slightly more difficult to take down than classic Blalock-Taussig shunt, and 
probably should be divided rather than ligated at the time of total correction . 
Leakage of the serous fluid through the interstices of the fabric of the PTFE occurs 
in 10-15 % of patients ,false aneurysm formation ,partial or complete obstruction 
of the subclavian artery distal to the graft has been reported and infection of MBTS 
is rare[Wells ,1991]. 
I-10   Successful Shunts:-A successful shunt decreases cyanosis, polycythemia 
and  symptoms with which they are associated.The murmur of functioning shunt in 
the early post operative period can be well heard when the bell of a stethoscope is 
applied to the open endotracheal tube connection briefly during a quiescent phase 
of respiration[Godart ,1998].
 
 
Patient and methods  
Between June 1993 and June 2015 (12 years), 29 patients received Blalock-
Taussig shunt as palliation for different CCHD . Four patients had CBTS, but the 
majority had MBTS. There were 19 males and 10 females (M/F : 1.9:1). Their age 
ranged between 15 days to 13 years, with a mean age of 49 ± 59 months. The patients' 
weights ranged between 3-30 Kg, with a mean weight of 11.3 ± 7.5 Kg.
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Types of Blalock- Taussig shunts
Left modified BTS 48%
Left classical BTS 38%
Right classical BTS 7%
Right modifief BTS 7%
Table (I):  Patient's age and weight relative to shunt failure. 
Age 
No. of 
patients 
Weight 
range (Kg) 
Average 
(Kg) 
Failure Overall failure % 
<1 month 1 3 3 0 0 0 
1-6 months 6 4-6 4.5 4 66 14 
6 month-1year 6 5-8 6.5 3 50 10 
1-3 year 5 7-15 10.6 0 0 0 
3-6 year 3 13-14 13.6 2 66 7 
> 6 year 8 12-30 20.5 3 37 10 
 
 
  
                    
 
 
 
 
 
                                                                                                                  
 
Figure (1) show types of shunts 
Pre-operative diagnosis was confirmed by echocardiography and cardiac 
catheterization. The majority of the patients had TOF (n=14), and to less extent TGA 
(n=6), DOV (n=5), T.at (n=3), and severe PS with ASD (n=1). The aortic arch was 
left sided in 27 patients and right sided in two patients. The size of the main 
pulmonary artery ranges between atretic to 17mm in diameter, as reported by 
echocardiography. 
 
 
 
 
 
 
 
Figure ( 2 ) size of main pulmonary artery 
 
The clinical data were collected retrospectively from patients' records.Cyanotic 
spells were present in all patients, with growth retardation, and recurrent chest 
infections in 25 patients. Three patients had associated history of subacute bacterial 
endocarditis(SBE) and one patient had acute renal failure(ARF) and ischemia of left 
lower limb .All patients had elevated Hb/Hct value ranging from 16/50 to 23/70, 
except the patient with ARF (14/43).Pre-operative cardiac catheterizations were 
performed for only 7 patients, among whom four patients with TOF, two with double 
outlet right ventricle( DORV), and one with TGA. One patient had unfunctioning 
MBTS that was performed two years ago. All shunts were constructed through left 
(n=16) or right (n=13) lateral thoractomy, via fourth intercostals space.In MBTS, a 
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conduit of Gore-Tex (PTFE) vascular graft was used, the size of which ranges 
between 3 to 8 mm. The size of the graft was selected according to the body surface 
area, and the diameter of the subclavian artery and pulmonary artery. One patient who 
was 15 days of age had bilateral thoracotomy at the same time of operation. First right 
thoracotomy was performed and discovered to have right-sided aortic with PDA, then 
left thoracotomy with MBTS had to be done. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure ( 3 ) size of grafit in modified shunt 
 
CBTS was performed on four patients, three of them were opposite to aortic 
arch and the fourth was on the same side of the aortic arch.Shunt patency was 
determined using a combination of clinical findings, echocardiography and cardiac 
catheterization. The criteria used to define that a given shunt failed to continue 
providing satisfactory palliation consists of any one of the followings: Progressive 
cyanosis with absence of continuous shunt murmur ,Occlusion of the shunt 
documented by echocardiography  and Occlusion of the shunt documented by cardiac 
catheterization.The length of satisfactory palliation for any given shunt was 
determined to that point in time when:-(I).The shunt failed as defined above (II).The 
shunt was electively taken down at a complete repair. (III).Death from any reason. 
Patients were followed-up for a period range from  2 months to 7 years post-
operatively as documented by patients record files  
 
Results  
After surgery, all surviving patients (n=28) were kept in ICU. The period of 
post-operative care at ICU ranged between 1-22 days. Most of the patients (17) stayed 
one day in ICU, including four mortalities. The other 11 patients stayed between 2-22 
days. Twenty five patients received different doses of heparin ranging between 20-
1000 IU/Kg/24 hours. Three patients received aspirin tablet 100mg/24 hours. The 
overall shunt failures were 12 shunts (41%), all of whom had MBTS. Operative 
mortality (within 30 days from operation) occurred in seven patients (24%), including 
one intra-operative death. Of the other 6 post-operative deaths, four were shunt failure 
related, and two had functioning shunt as documented clinically and 
echocardiographically. 
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Table (IV):  Diseases and early shunt failure rates. 
Diagnosis No. of patients 
Shunts 
MBTS 
failure 
MBTS CBTS No. % 
1- TOF 14 10 4 5 35 
2- TGA +  LVOTO 6 6 -- 2 33 
3- DOV + PS 5 5 -- 2 40 
4- T. Atr. 3 3 -- 3 100 
5- PS + ASD 1 1 - -- 0 
Total 29 25 4 12 41 
TOF  Tetralogy of Fallot                         TGA  Transposition of Great Arteries                  DOV  Double Outlet Ventricle              
 TA    Tricuspid Atresia                             PS    Pulmonary Stenosis                                     ASD Atrial Septal Defect 
CCHD Cyanotic Congenital Heart          CBTS  Classical Blalock – Taussing Shunt          MBTS Modified Blalock – Taussig 
Shunt PTFE  Polytetrafloruethylen                                  DORV Double Outlet Right Ventricle           PA  Pulmonary Atresia  
VSD Ventricular Septal Defect                       Hb  Hemoglobin Concentration                     BTS  Blalock – Taussig Shunt     
DOLV Double outlet Left ventricle               LVOTO Left Ventricular outflow tract Obstruction    ARF acute renal failuer 
 
 
 
Table (V):  details of early shunt failure and mortality  
Diagnosis 
Age in 
months 
Weight 
in Kg 
Main 
pulmonary 
artery size 
mm 
Graft 
size 
mm 
Side of 
MBTS to 
aortic arch 
Graft 
failure 
Cause of 
mortality 
1- TOF 4 4 5 4 Ipsilateral + 
Cardiac 
arrhythmia 
2- TOF 48 13 6 6 Contralateral + 
Sudden 
cardio-
pulmonary 
collapse 
3- T.Atr. ASD, 
VSD 
4 4 <3 4 Contralateral + 
Intra-
operative 
death 
4- T.Atr. ASD, 
VSD 
5 6 6 5 Ipsilateral + 
Respiratory 
failure 
5- DORV, PS 9 5 5 4 Ipsilateral + 
Respiratory 
failure 
6- DORV, 
DIRV, PFO, 
PS, VSD 
122 14.5 8 6 Ipsilateral - 
Respiratory 
failure 
7- Severe PS, 
ASD, Intact 
IVS 
2 4 4 5 Contralateral - 
Cardiac 
arrhythmia 
Seven late shunt failures occurred during the follow-up period (24%). The graft 
size in those patients was 5 to 6mm. One of these patients who had associated ARF 
together with another three patients died at home or hospital. Two patients were still 
alive, and the seventh patient underwent total correction. Another late death was not 
related to shunt failure . Graft failure was observed more with size 6 mm. 
 
 
 
 
 
 
Journal of Babylon University/Pure and Applied Sciences/ No.(1)/ Vol.(26): 2018 
272 
 
Table (VI):  Details of late shunt failures and mortalities. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table (VII):  Post-operative complications. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Different post-operative complications occurred, yet most of them were curable. 
Post-operative cardiac catheterization was performed for only 5 patients through a 
period ranging between 1 and 7 years. Most of these patients were without distortion 
of the pulmonary artery  and had patent shunts.  
 
 
 
 
Complications No. of patients Functioning BTS Outcome 
Bleeding 1 + Alive 
Bacterial endocarditis 3 - 2 died 
Hypoxia 1 + Alive 
Chest infection 1 + Alive 
Pericardial effusion 1 - Died 
Pleural effusion 1 + Alive 
Wound infection 1 + alive 
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1- TOF 56 19 6 6 25 Occluded 
Progressive 
cyanosis 
Total 
correction 
2- TOF 90 16 6 6 40 Occluded  
Progressive 
cyanosis 
Died at 
hospital 
3- TOF 98 16 7 6 50 
Inadequate 
flow 
- progressive 
cyanosis 
- Absence of shunt 
murmur 
Alive 
4- D. TGA 7 5 4 5 5 -- 
Progressive 
cyanosis 
Died at 
home 
5- D. TGA, 
VSD, PS 
7 8 12 6 34 
Inadequate 
flow 
Progressive 
cyanosis 
Died at 
home 
6- T.Atr. ASD, 
PDA 
144 26 7 6 62 
Inadequate 
flow  
Progressive 
cyanosis 
Alive 
7- DORV, P.S 10 8 7 5 5 
Inadequate 
flow 
- Mild cyanosis 
- Hypoxia 
Died at 
hospital 
8- TOF 0.5 3 3 3 35 Good flow  Mild cyanosis 
Died at 
home 
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Table (VIII):  Post-operative cardiac catheterization. 
 
Table (II):  ICU stay, shunt failure and mortality (exclusing one intra-operative shunt failure and death). 
 
Disscusion 
The use of shunting procedure in Ibn Al-Bitar Center remains limited (4.5%) as 
compared to others. This may be due to late referral of patients, which makes most 
such patients amenable for total correction of their CCHD. Many infants and children 
were diagnosed and sent for shunting on the basis of echocardiography only, because 
of its reliability, accuracy, and ease, without the need for cardiac catheterization 
which is becomes the interventional tool which is more usable  than  the traditional 
diagnostic procedure. Similarly, in this study, cardiac catheterization was needed only 
for 7 patients (24%).Half of BTS were performed in patients with TOF, and it remains 
the commonest CCHD presented in our hospital (75%).   This study included 29 
patients who underwent BTS,  4 of them had CBTS and the other 25 patients had 
MBTS. this agrees with another study done at Saudi Arabia at Prince Sultan Cardiac 
Center by Dr Khalid Al Jubair and associateds  at 2008.It shows that 23% of patients 
do CBTS while 77% do MBTS in 478 patients[Khalid A. Al Jubair,2008] . In Our 
study, the majority of patients were over 3 months of age (n=26), and most of them 
had MBTS (n=23) due to late referral of patients and this disagrees with Dr.khalid Al 
Jubair study which showed that the majority of patients were below 3 monthes of age 
(78 pateints below one week ,270 from 1 to 12 weeks and 198 over one year of age) 
[Khalid A. Al Jubair,2008]. 
 Similarly, in this study, 13 MBTS were performed on the side of aortic arch 
and 12 on opposite side. Three MBTS that were constructed on ipsilateral side of 
aortic arch resulted in over flow to the lung and respiratory failure (23%). This may 
support the application of contralateral MBTS, especially for its ease to be taken 
down. CBTS were constructed in 4 patients, one of them was performed on the same 
side of aortic arch with arterioplasy of subclavian artery, because of stenotic left 
pulmonary artery and oligemic left lung. Following BTS, immediate increase in O2 
Disease 
Type of 
BTS 
Post-operative catheterization 
date (years) 
Pulmonary 
artery distortion 
Shunt 
patency 
D-TGA RMBT 2 + - 
DORV RMBT 1 - + 
TOF LMBT 3 - + 
TOF LMBT 2 - + 
TOF LCBT 7 - + 
Time No. of patients Shunt failure mortality 
1 day 17 4 4 
2 days 4 -- -- 
3 days 3 -- 1 
4 days 1 -- -- 
> 5 days (5-22) 3 -- 1 
Total 28 4 6 
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saturation appears post-operatively in functioning shunt. This increase was 
statistically significant in our study, that agrees with Al Jubair study [Khalid A. Al 
Jubair,2008]. 
In this study, different doses of heparin were given to most of patients post-
operatively in ICU, and shunt failures were found to be heparin dose related. Only one 
patient had significant post-operative bleeding that agrees with Al Jubaier study which 
showed that the ues of heparin decreases the shunt failure[Khalid A. Al Jubair,2008].  
Out the total 29 shunts of study, 12 patients had shunt failures, according to the 
criteria of shunt failure. Two alive patients had progressive cyanosis, and were 
regarded as shunt failure, although the shunt was still patent, an inadequate flow by 
echo-Doppler was reported, and no further procedure was done. Thus early shunt 
failure rate was 41% and late shunt failure was 27% while Al jubair study recorded 9-
3% of shunt failure. This high shunt failure rate in comparison to other studies may be 
due to the smaller size of main pulmonary artery in our study. 35% of total early shunt 
failures occurred in patients with TOF. All three patients with TA resulted in shunt 
failure. This may be due to high frequency of TOF in this study.   In this study, six 
shunt failures occurred in MBTS with graft size 6mm and three in graft size 5mm, for 
equal number of patients . Yet, this was of no statistical significance.  In other studies, 
the early operative mortality ranged between 11 % for MBTS to 8% for CBTS and 
most of these mortalities were not related to shunt failures[Sakai K,1987]. In this 
study, early mortality took place in seven patients (24%), five of them were due to 
shunt failure. The other two mortalities may be related to the younger age (2 months) 
or complex congenital cardiac pathology. Late mortality rate was 17% (n=5 patients), 
which is more than it was in other studies ( Al jubair study show over all hospital 
mortality 2.9 % ), and most of them were related to shunt failure (n=4). The 
explanation for this result may be related to poor compliance of the patient's 
attendance for follow up and assessment for the need for further intervention, as total 
correction was done for only one patient in this series.   Very young age and severity 
of cardiac malformation have been clearly determined as a major risk factor for deaths 
in large series of shunting procedures. With reference to patients' age, out of the total 
of 12 deaths, five patients (41%) were less than 6 months of age, that agrees with Al 
jubair study .  In this study, the palliation time within 3 years of shunting was 58%, 
which is comparable to other studies. The overall mean shunts survival was 26.4 ± 
30.1 months, and no shunt failed between 6 and 24 months post-operatively. This 
indicated that shunt patency was the best up to two years (68%) from time of 
operation, that agrees with  the study by Sakai and associated at 1987 which showed 
that the patency rate for 3 years range from 88.8 % for MBTS to 78 % for CBTS[33] .   
The mean patients' survival time with MBTS was just over 1 year for patients aged 6 
months or less at operation, but  it was 13 months longer for those of more than 6 
months of age. These findings were nearly the same for patients 4.5 Kg or less Vs. 
those more than 4.5 Kg and patients with MPA size 5mm or less Vs. those more than 
5mm. The size of MPA 5 mm or less appears to be the stronger risk factor than the 
patients' age and the size of grafts. that agrees with Al Jubair study which showed 
high mortality when pulmonary artery diameter was less than 4 mm. At 36 months 
after operation, 56% of all shunts were functioning in patients with MPA size > 5mm, 
33% in MPA ≤ 5mm. Another important risk factor is the very young age, as 16% of 
shunts were functioning in the age group 6 months or less, and 63% in the group  
were more than 6 months of age.  In our study, 4 cases (14%) with MBTS showed 
distorted pulmonary artery, documented by echocardiography (n=3) and cardiac 
catheterization (n=1) and not related to shunt type. This agrees with Francois Godart 
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and associated study at 1998  . All those patients had un functioning shunts [Francois 
Godart,1998] . Doppler echocardiography is a highly reliable method for early post-
operative evaluation of patients with BTS. Post-operative cardiac catheterization done 
in 17% of patients showed that the graft was functional in cases that had no 
pulmonary artery distortion. 
  
Conclusion 
MBTS is one of palliative procedures for CCHD .Although BTS may be 
indicated at any age, it is one of the higher risk in those who were less than 6 months 
of age . Care should be taken during shunt procedures to avoid pulmonary artery 
distortion, as this may lead to shunt failure ,The size of main pulmonary artery proved 
to be the most important determinant of BTS patency.   
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